Breakthrough Therapy Designation Supported by Integrated Long-Term Clinical Data Demonstrating Normalization in Cerebral Spinal Fluid Heparan Sulfate Non-Reducing End (CSF HS-NRE) U.S. FDA Confirmed ...
You can check your participation: look for UNIV300 on your transcript. If you will attend UTA training in Fall 2025 or Spring 2026, your training will be out of date on July 30, 2028 (at the end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback